These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 29204154)

  • 1. Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease.
    Helley MP; Pinnell J; Sportelli C; Tieu K
    Front Genet; 2017; 8():177. PubMed ID: 29204154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunctions in Parkinson's disease.
    Gautier CA; Corti O; Brice A
    Rev Neurol (Paris); 2014 May; 170(5):339-43. PubMed ID: 24119854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Insight into the Molecular Mechanism of Mitochondrial Toxicant-induced Neuronal Apoptosis in Parkinson's Disease.
    Brahadeeswaran S; Lateef M; Calivarathan L
    Curr Mol Med; 2023; 23(1):63-75. PubMed ID: 35125081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease.
    Pang SY; Ho PW; Liu HF; Leung CT; Li L; Chang EES; Ramsden DB; Ho SL
    Transl Neurodegener; 2019; 8():23. PubMed ID: 31428316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current perspective of mitochondrial biology in Parkinson's disease.
    Ammal Kaidery N; Thomas B
    Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Gene-Environment Interactions in Parkinson's Disease.
    Fleming SM
    Curr Environ Health Rep; 2017 Jun; 4(2):192-199. PubMed ID: 28417442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic mutations and mitochondrial toxins shed new light on the pathogenesis of Parkinson's disease.
    Sato S; Hattori N
    Parkinsons Dis; 2011; 2011():979231. PubMed ID: 21860779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between Lysosomes and Mitochondria in Parkinson's Disease.
    Plotegher N; Duchen MR
    Front Cell Dev Biol; 2017; 5():110. PubMed ID: 29312935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
    Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model.
    Ray A; Martinez BA; Berkowitz LA; Caldwell GA; Caldwell KA
    Cell Death Dis; 2014 Jan; 5(1):e984. PubMed ID: 24407237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Mani S; Sevanan M; Krishnamoorthy A; Sekar S
    Neurol Sci; 2021 Nov; 42(11):4459-4469. PubMed ID: 34480241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Emerging Role of
    Grossmann D; Berenguer-Escuder C; Chemla A; Arena G; Krüger R
    Front Neurol; 2020; 11():587. PubMed ID: 33041957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the complex role of mitochondria in Parkinson's disease.
    Grünewald A; Kumar KR; Sue CM
    Prog Neurobiol; 2019 Jun; 177():73-93. PubMed ID: 30219247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Dysfunction and Parkinson's Disease: Pathogenesis and Therapeutic Strategies.
    Moradi Vastegani S; Nasrolahi A; Ghaderi S; Belali R; Rashno M; Farzaneh M; Khoshnam SE
    Neurochem Res; 2023 Aug; 48(8):2285-2308. PubMed ID: 36943668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria and Parkinson's Disease: Clinical, Molecular, and Translational Aspects.
    Borsche M; Pereira SL; Klein C; Grünewald A
    J Parkinsons Dis; 2021; 11(1):45-60. PubMed ID: 33074190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson's Disease.
    Polito L; Greco A; Seripa D
    Parkinsons Dis; 2016; 2016():6465793. PubMed ID: 26942037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction in genetic animal models of Parkinson's disease.
    Trancikova A; Tsika E; Moore DJ
    Antioxid Redox Signal; 2012 May; 16(9):896-919. PubMed ID: 21848447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease.
    Sohrabi T; Mirzaei-Behbahani B; Zadali R; Pirhaghi M; Morozova-Roche LA; Meratan AA
    J Mol Biol; 2023 Jun; 435(12):167992. PubMed ID: 36736886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.